Jamie Moore
SVP, Global Head of Technical Development, Gilead Sciences
9th International Conference on Accelerating Biopharmaceutical Development (AccBio 2025)
April 9, 2025 to April 11, 2025
Add to Calendar
This conference series brings together senior thought leaders from across multiple disciplines to discuss strategies, technologies and capabilities that accelerate biopharmaceutical development. This year’s program will focus on artificial intelligence, sustainability, and novel process technology development tools that span drug substance and drug products. Explore the transformative potential of patient-centric drug delivery systems as high concentration biologics become increasingly prevalent.
New strategies that minimize environmental impact, optimize resource use, and promote green practices benefitting the planet are driving biopharma sector to invest differently. AccBio 2025 is not just an event, it’s a gathering of industry leaders who are driving change and igniting new ideas.
Poster Submission Deadline Extended: February 18, 2025
Early Bird Deadline: February 18, 2025
Join us to explore how AI is revolutionizing biomanufacturing with cutting edge innovations that enhance efficiency, reduce costs, and improve product quality.
Featured Speakers
-
-
Brendan Hughes
Biotech Veteran , Private Consultancy -
Angela Coxon
Vice President of R&D , Amgen, Inc -
Bruce Lawler
Managing Director , MIT Machine Intelligence for Manufacturing and Operations (MIT MIMO) -
John Eschelbach
Product Strategy Leader, Genentech -
Parag Kolhe
Senior Director, Pharmaceutical Research and Development, Pfizer -
Sachin Mittal
Executive Director (Head) Vaccine Drug Product Development , Merck -
Karthik Vaideeswaran
Associate Vice President, Device Development and Technology, Merck -
Jeremy Shaver
Senior Director, Pfizer -
Kyle McElearney
Director Process Development , Amgen -
Karl Britt
R&D leader and Head of Product Sustainability, Cytiva -
Victoria Sluzky
Chief Technology Officer (CTO) , Elektrofi Inc. -
Alec Nielsen
Co-Founder and CEO , Asimov -
Vinod Bulusu
Executive Director,, GTO, AZ -
Elçin Içten-Gençer
Associate Director, Amgen -
Adithya Balasubramanian
Director , ten23 Health -
Sherry Gu
Executive Vice President and Chief Technology Officer, WuXi Biologics’ -
Michael Coolbaugh
Head of Advanced Manufacturing Implementation, Purification Process Development, Sanofi -
Ouwei Wang
CEO & Founder , Pow.Bio
Sponsors
I am eagerly looking forward to listening and discussing strategies and tools with our distinguished speakers that will help us achieve acceleration and bring more medicines to our patients.
Reasons to Attend
- This is the conference to attend if you want to be at the forefront of applications of Artificial Intelligence, machine learning and big data to accelerate biopharmaceutical development and manufacturing.
- This conference is unique in that it attracts senior level attendees and leaders.
- The event will showcase innovations that ensure that medications are tailored to meet individual patient needs.
- Be part of the cutting-edge technological innovations and developments in biotechnology.
- Attend presentations focusing on topics impacting society, including cell therapy, gene therapy, live virus therapies, mRNA, and newer, more complex protein therapeutics and vaccines.
Who Should Attend
- VP to CEO level thought leaders from the biopharmaceutical development and manufacturing fields
- Senior-level scientists and researchers from industry, government, and academia
- R&D leaders
- Program Managers and industry executives
- Associated professionals in the fields of bioengineering, biotechnology, and bioprocessing